References
- Hawrelak J. Giardiasis: pathophysiology and management. Altern Med Rev 2003; 8: 129–42
- Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981–8
- Surawicz CM, McFarland LV, Elmer G, Chinn J. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285–7
- Czerucka D, Rampal P. Experimental effects of Saccharomyces boulardii on diarrhoeal pathogens. Microbes Infect 2002; 4: 733–9
- Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27: 323–32
- Buts JP, Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 251–6
- Periti P, Tonelli F. Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J Chemother 2001; 13: 473–93
- Meloni BP, Thompson RC, Reynoldson JA, Seville P. Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans R Soc Trop Med Hyg 1990; 84: 375–9
- Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33: 22–8
- Guillot CC, Bacallao EG, Dominguez MSC, Garcia MF, Gutierrez PM. Effects of Saccharomyces boulardii in children with chronic diarrhoea, especially cases due to giardiasis. Rev Mex De Puericultura Y Pediatria 1995; 2: 1–5
- Thompson RC. The zoonotic significance and molecular epidemiology of Giardia and giardiasis. Vet Parasitol 2004; 126: 15–35
- Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 2003; 9: 1832–3
- Rigothier MC, Maccario J, Gayral P. Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res 1994; 80: 10–5
- Jahn HU, Ullrich R, Schneider T, Liehr RM, Schieferdecker HL, Holst H, et al. Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion 1996; 57: 95–104
- Buts JP, Bernasconi P, van Craynest MP, Maldague P, De Meyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 1986; 20: 192–6